Skip to main content
Erschienen in: International Urology and Nephrology 9/2022

08.07.2022 | Urology - Original Paper

Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms

verfasst von: Wan-Ru Yu, Wei-Chuan Chang, Hann-Chorng Kuo

Erschienen in: International Urology and Nephrology | Ausgabe 9/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In men, lower urinary tract symptoms (LUTS) similar to interstitial cystitis/bladder pain syndrome (IC/BPS) are difficult to diagnose, and treatment outcomes are poor. This study investigated clinical characteristics and videourodynamic study (VUDS) parameters, pathophysiology, and treatment outcomes in men with IC-like LUTS.

Methods

Men with frequency, urgency, dysuria, and bladder pain initially diagnosed as IC/BPS by ESSIC criteria were assessed to rule out other lower urinary tract diseases (LUTD) by voiding diary, digitorectal examination, urinalysis, VUDS, and cystoscopic hydrodistention. Subsequent treatments for LUTD and specific treatment for IC/BPS were based on VUDS and cystoscopic findings. Clinical VUDS characteristics and treatment outcomes were compared with those of women with IC/BPS.

Results

Seventy consecutive men (median age 54.5 years) were enrolled. The median maximum bladder capacity under cystoscopic hydrodistention was 650 mL (IQR 495–763) and glomerulation grade was 2 (1.0–2.0). The patients had moderate anxiety and depression severity; 49% had improved treatment outcomes. On VUDS, 42 (60%) patients had variable LUTD, including detrusor overactivity (n = 14), bladder neck dysfunction (n = 15), dysfunctional voiding (n = 3), and poor relaxation of the external sphincter (n = 24); also, 22 (31.4%) had a previous bladder outlet procedure. The self-reported treatment outcome was significantly better for patients with vs. without LUTD (p = 0.014).

Conclusions

Men with IC-like LUTS diagnosed as IC/BPS may have bladder outlet dysfunction as well as bladder dysfunction, causing a hypersensitive and painful bladder. The IC-like symptoms in the patients with LUTD might, in part, originated from bladder outlet dysfunction rather than the bladder alone.
Literatur
1.
Zurück zum Zitat Guzmán-Esquivel J, Delgado-Enciso I, Guzmán-Solórzano JA, Urtiz-Licea AJ, Parra-Lomeli H, Ríos-Bracamontes EF, Murillo-Zamora E (2021) Erectile dysfunction, lower urinary tract symptoms, and quality of life in men above 50 years of age. Arch Esp Urol 74:224–230PubMed Guzmán-Esquivel J, Delgado-Enciso I, Guzmán-Solórzano JA, Urtiz-Licea AJ, Parra-Lomeli H, Ríos-Bracamontes EF, Murillo-Zamora E (2021) Erectile dysfunction, lower urinary tract symptoms, and quality of life in men above 50 years of age. Arch Esp Urol 74:224–230PubMed
2.
Zurück zum Zitat Liu SP, Chuang YC, Sumarsono B, Chang HC (2019) The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan. J Formos Med Assoc 118:170–178CrossRef Liu SP, Chuang YC, Sumarsono B, Chang HC (2019) The prevalence and bother of lower urinary tract symptoms in men and women aged 40 years or over in Taiwan. J Formos Med Assoc 118:170–178CrossRef
3.
Zurück zum Zitat Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Cl C, Tsui KH (2018) Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatr 18:1–7CrossRef Lin YH, Hou CP, Chen TH, Juang HH, Chang PL, Yang PS, Cl C, Tsui KH (2018) Transurethral resection of the prostate provides more favorable clinical outcomes compared with conservative medical treatment in patients with urinary retention caused by benign prostatic obstruction. BMC Geriatr 18:1–7CrossRef
4.
Zurück zum Zitat Clemens JQ, Meenan RT, O’Keeffe-Rosetti MC, Gao SY, Brown SO, Calhoun EA (2006) Prevalence of prostatitis-like symptoms in a managed care population. J Urol 176:593–596CrossRef Clemens JQ, Meenan RT, O’Keeffe-Rosetti MC, Gao SY, Brown SO, Calhoun EA (2006) Prevalence of prostatitis-like symptoms in a managed care population. J Urol 176:593–596CrossRef
5.
Zurück zum Zitat Hanno PM, Erickson D, Moldwin R, Faraday MM (2015) Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 193:1545–1553CrossRef Hanno PM, Erickson D, Moldwin R, Faraday MM (2015) Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 193:1545–1553CrossRef
6.
Zurück zum Zitat Jiang YH, Liao CH, Kuo HC (2018) Role of bladder dysfunction in men with lower urinary tract symptoms refractory to alpha-blocker therapy: a video-urodynamic analysis. Lower Urin Tract Symptoms 10:32–37CrossRef Jiang YH, Liao CH, Kuo HC (2018) Role of bladder dysfunction in men with lower urinary tract symptoms refractory to alpha-blocker therapy: a video-urodynamic analysis. Lower Urin Tract Symptoms 10:32–37CrossRef
7.
Zurück zum Zitat Jhang JF, Kuo HC (2017) New insights into interstitial cystitis and chronic pelvic pain syndromes. Nature Rev Urol 14:69–70CrossRef Jhang JF, Kuo HC (2017) New insights into interstitial cystitis and chronic pelvic pain syndromes. Nature Rev Urol 14:69–70CrossRef
8.
Zurück zum Zitat Akiyama Y (2020) Update on the pathophysiology of interstitial cystitis/bladder pain syndrome. Curr Bladder Dysfunct Rep 15:1–8CrossRef Akiyama Y (2020) Update on the pathophysiology of interstitial cystitis/bladder pain syndrome. Curr Bladder Dysfunct Rep 15:1–8CrossRef
9.
Zurück zum Zitat Shoskes DA, Nickel JC, Rackley R, Pontari M (2009) Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 12:177–183CrossRef Shoskes DA, Nickel JC, Rackley R, Pontari M (2009) Clinical phenotyping in chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis: a management strategy for urologic chronic pelvic pain syndromes. Prostate Cancer Prostatic Dis 12:177–183CrossRef
10.
Zurück zum Zitat Forrest JB, Vo Q (2001) Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men. Urology 57:26–29CrossRef Forrest JB, Vo Q (2001) Observations on the presentation, diagnosis, and treatment of interstitial cystitis in men. Urology 57:26–29CrossRef
11.
Zurück zum Zitat Arora HC, Shoskes DA (2015) The enigma of men with interstitial cystitis/bladder pain syndrome. Trans Androl Urol 4:668–676 Arora HC, Shoskes DA (2015) The enigma of men with interstitial cystitis/bladder pain syndrome. Trans Androl Urol 4:668–676
12.
Zurück zum Zitat Lubeck DP, Whitmore K, Sant GR et al (2001) Psychometric validation of the OLeary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology 57(Suppl 1):62–66CrossRef Lubeck DP, Whitmore K, Sant GR et al (2001) Psychometric validation of the OLeary-Sant interstitial cystitis symptom index in a clinical trial of pentosan polysulfate sodium. Urology 57(Suppl 1):62–66CrossRef
14.
Zurück zum Zitat Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49CrossRef Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A (2003) The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 61:37–49CrossRef
15.
Zurück zum Zitat Ke QS, Jiang YH, Kuo HC (2015) Role of bladder neck and urethral sphincter dysfunction in men with persistent bothersome lower urinary tract symptoms after alpha-1 blocker therapy. Lower Urin Tract Symptoms 7:143–148CrossRef Ke QS, Jiang YH, Kuo HC (2015) Role of bladder neck and urethral sphincter dysfunction in men with persistent bothersome lower urinary tract symptoms after alpha-1 blocker therapy. Lower Urin Tract Symptoms 7:143–148CrossRef
16.
Zurück zum Zitat Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D, Lin AT, Kuo HC, Lee MH, Oh SJ, Kim JC, Lee KS (2020) Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol 27:578–589CrossRef Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D, Lin AT, Kuo HC, Lee MH, Oh SJ, Kim JC, Lee KS (2020) Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol 27:578–589CrossRef
17.
Zurück zum Zitat Hanno PM, Sant GR (2001) Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis. Urology 57:2–6CrossRef Hanno PM, Sant GR (2001) Clinical highlights of the National Institute of Diabetes and Digestive and Kidney Diseases/Interstitial Cystitis Association scientific conference on interstitial cystitis. Urology 57:2–6CrossRef
18.
Zurück zum Zitat Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67CrossRef Van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, Elneil S, Fall M, Hohlbrugger G, Irwin P (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol 53:60–67CrossRef
19.
Zurück zum Zitat Yu WR, Jhang JF, Ho HC, Jiang YH, Lee CL, Hsu YH, Kuo HC (2021) Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment. Sci Rep 11:1–9CrossRef Yu WR, Jhang JF, Ho HC, Jiang YH, Lee CL, Hsu YH, Kuo HC (2021) Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment. Sci Rep 11:1–9CrossRef
20.
Zurück zum Zitat Propert K, Mayer R, Wang Y, Sant G, Hanno P, Peters K, Kusek J, Group ICCT (2006) Responsiveness of symptom scales for interstitial cystitis. Urology 67:55–59CrossRef Propert K, Mayer R, Wang Y, Sant G, Hanno P, Peters K, Kusek J, Group ICCT (2006) Responsiveness of symptom scales for interstitial cystitis. Urology 67:55–59CrossRef
22.
Zurück zum Zitat Abdelmoteleb H, Jefferies ER, Drake MJ (2016) Assessment and management of male lower urinary tract symptoms (LUTS). Int J Surg 25:164–171CrossRef Abdelmoteleb H, Jefferies ER, Drake MJ (2016) Assessment and management of male lower urinary tract symptoms (LUTS). Int J Surg 25:164–171CrossRef
23.
Zurück zum Zitat von Gontard A, Vrijens D, Selai C, Mosiello G, Panicker J, van Koeveringe G, Apostolidis A, Anding R (2019) Are psychological comorbidities important in the aetiology of lower urinary tract dysfunction—ICI-RS 2018? Neurourol Urodynam 38:S8–S17 von Gontard A, Vrijens D, Selai C, Mosiello G, Panicker J, van Koeveringe G, Apostolidis A, Anding R (2019) Are psychological comorbidities important in the aetiology of lower urinary tract dysfunction—ICI-RS 2018? Neurourol Urodynam 38:S8–S17
24.
Zurück zum Zitat Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, Oberpenning F, Williams AC (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57:35–48CrossRef Fall M, Baranowski AP, Elneil S, Engeler D, Hughes J, Messelink EJ, Oberpenning F, Williams AC (2010) EAU guidelines on chronic pelvic pain. Eur Urol 57:35–48CrossRef
25.
Zurück zum Zitat Jiang YH, Kuo HC (2014) Urothelial dysfunction and increased suburothelial inflammation of urinary bladder are involved in patients with upper urinary tract urolithiasis-clinical and immunohistochemistry study. PLoS ONE 9:e110754CrossRef Jiang YH, Kuo HC (2014) Urothelial dysfunction and increased suburothelial inflammation of urinary bladder are involved in patients with upper urinary tract urolithiasis-clinical and immunohistochemistry study. PLoS ONE 9:e110754CrossRef
26.
Zurück zum Zitat Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC (2007) Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 70:16–18CrossRef Peters KM, Carrico DJ, Kalinowski SE, Ibrahim IA, Diokno AC (2007) Prevalence of pelvic floor dysfunction in patients with interstitial cystitis. Urology 70:16–18CrossRef
27.
Zurück zum Zitat Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexabder RB, Farrar JT, O’Leary MP (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162:369–375CrossRef Litwin MS, McNaughton-Collins M, Fowler FJ, Nickel JC, Calhoun EA, Pontari MA, Alexabder RB, Farrar JT, O’Leary MP (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162:369–375CrossRef
28.
Zurück zum Zitat Nickel JC, Downey J, Ardern D, Clark J, Nickel K (2004) Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 172:551–554CrossRef Nickel JC, Downey J, Ardern D, Clark J, Nickel K (2004) Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome. J Urol 172:551–554CrossRef
29.
Zurück zum Zitat Forrest JB, Schmidt S (2004) Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: a common and frequently identical clinical entity. J Urol 172:2561–2562CrossRef Forrest JB, Schmidt S (2004) Interstitial cystitis, chronic nonbacterial prostatitis and chronic pelvic pain syndrome in men: a common and frequently identical clinical entity. J Urol 172:2561–2562CrossRef
30.
Zurück zum Zitat Haga N, Ogawa S, Yabe M, Akaihata H, Hata J, Sato Y, Ishibashi K, Hasegawa O, Kikuchi K, Shishido F (2014) Association between postoperative pelvic anatomic features on magnetic resonance imaging and lower tract urinary symptoms after radical prostatectomy. Urology 84:642–649CrossRef Haga N, Ogawa S, Yabe M, Akaihata H, Hata J, Sato Y, Ishibashi K, Hasegawa O, Kikuchi K, Shishido F (2014) Association between postoperative pelvic anatomic features on magnetic resonance imaging and lower tract urinary symptoms after radical prostatectomy. Urology 84:642–649CrossRef
31.
Zurück zum Zitat Yu WR, Chang WC, Kuo HC (2021) Voiding dysfunctions in patients with non-Hunner’s ulcer interstitial cystitis/bladder pain syndrome do not affect long-term treatment outcome. Int J Clin Pract 75:e14372PubMed Yu WR, Chang WC, Kuo HC (2021) Voiding dysfunctions in patients with non-Hunner’s ulcer interstitial cystitis/bladder pain syndrome do not affect long-term treatment outcome. Int J Clin Pract 75:e14372PubMed
32.
Zurück zum Zitat Nitti VW (2005) Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol 7(Suppl 6):S14PubMedPubMedCentral Nitti VW (2005) Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol 7(Suppl 6):S14PubMedPubMedCentral
Metadaten
Titel
Clinical presentation, videourodynamic characteristics, and treatment outcome in men with interstitial cystitis-like lower urinary tract symptoms
verfasst von
Wan-Ru Yu
Wei-Chuan Chang
Hann-Chorng Kuo
Publikationsdatum
08.07.2022
Verlag
Springer Netherlands
Erschienen in
International Urology and Nephrology / Ausgabe 9/2022
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-022-03294-2

Weitere Artikel der Ausgabe 9/2022

International Urology and Nephrology 9/2022 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Ist Fasten vor Koronarinterventionen wirklich nötig?

Wenn Eingriffe wie eine Koronarangiografie oder eine Koronarangioplastie anstehen, wird häufig empfohlen, in den Stunden zuvor nüchtern zu bleiben. Ein französisches Forscherteam hat diese Maßnahme hinterfragt.

Typ-2-Diabetes: Ernährungsunsicherheit vervierfacht Risiko für schwere Hypoglykämien

04.06.2024 Typ-2-Diabetes Nachrichten

Wenn ältere Menschen mit Typ-2-Diabetes Schwierigkeiten beim Beschaffen und Zubereiten von Mahlzeiten haben, geht dies mit einem deutlich gesteigerten Risiko für schwere Hypoglykämien einher.

Mehr Brustkrebs, aber weniger andere gynäkologische Tumoren mit Levonorgestrel-IUS

04.06.2024 Levonorgestrel Nachrichten

Unter Frauen, die ein Levonorgestrel-freisetzendes intrauterines System (IUS) verwenden, ist die Brustkrebsrate um 13% erhöht. Dafür kommt es deutlich seltener zu Endometrium-, Zervix- und Ovarialkarzinomen.

GLP-1-Agonist Semaglutid wirkt kardio- und nephroprotektiv

03.06.2024 Semaglutid Nachrichten

Der GLP-1-Agonist Semaglutid hat in der FLOW-Studie bewiesen, dass sich damit die Progression chronischer Nierenerkrankungen bei Patienten mit Typ-2-Diabetes bremsen lässt. Auch in kardiovaskulärer Hinsicht war die Therapie erfolgreich.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.